Nutritional challenges and solutions for individuals living with cancer

• Member: $0.00 Save 100%
• Student Member: $0.00 Save 100%
• Non-Member: $0.00

View Related Content by:

Speakers:

Thomas Jagoe, Julie Tanguay-Gordon

Tags:

Speakers:

• Thomas Jagoe, MD, PhD, FRCP(UK)  (McGill University)
• Julie Tanguay-Gordon, RD (The Ottawa Cancer Centre)

WEBINAR DESCRIPTION

Nutritional challenges and solutions for individuals living with cancer Malnutrition is prevalent in people with cancer, and has detrimental effects on quality of life, treatment tolerance, and survival. This conference session addresses the complex challenges of malnutrition in oncology patients and emphasizes the need for individualized and multimodal approaches. First, the attendees will learn about the multifaceted nature of cancer cachexia, and the involvement of a variety of organs and physiological systems as drivers of cachexia. While current models acknowledge the multiple contributing factors, a key challenge to treating cachexia has been identifying the dominant driving mechanisms in each patient to tailor interventions effectively. Individualized treatment may be made possible through the advancement of biomarkers to enable targeting of drug and nutritional therapies in the future. The second speaker emphasizes the importance of managing nutrition impact symptoms (NIS), which arise from tumors, treatments, and psychosocial factors, to prevent weight loss and muscle wasting. Through a real-life example, practical approaches to managing complex symptoms and addressing challenges of enteral feeding in oncology will be discussed. You will leave this session with new knowledge and appreciation of the multifactorial contributors to malnutrition in people with cancer but also empowered to address these challenges to enhance care in the future.

Moderator: Vera Mazurak (University of Alberta)

ABOUT THE SPEAKERS

Thomas Jagoe is Director of the McGill Cancer Nutrition Rehabilitation (CNR) Program and medical lead for the CNR clinic at the Jewish General Hospital in Montreal. He trained in Internal Medicine and Pulmonology in the UK and completed a PhD on mechanisms of nutritional depletion in patients with early lung cancer. As a Fulbright Scholar and postdoc in Fred Goldberg lab at Harvard Medical School (1999-2002) he studied molecular mechanisms of muscle wasting. Using microarrays to identify new genes involved in muscle wasting, including atrogin-1 (Fbxo32), he and colleagues described common transcriptional adaptations shared by different experimental models of muscle wasting. In 2002 Dr Jagoe took up a post as a Senior Lecturer and Clinical Researcher at Liverpool University, UK and in 2007 he moved to Montreal to take over as Director of the McGill CNR program. The CNR clinic uses an integrated multidisciplinary approach to evaluate and treat different aspects of the cachexia syndrome. With members of the CNR team, Dr Jagoe continues to publish research on different aspects of clinical care of patients with cachexia.

Julie Tanguay-Gordon is a registered dietitian at The Ottawa Hospital Cancer Centre’s Psychosocial Oncology Program. After earning her Bachelor of Science in Nutritional Sciences from McGill University, she completed her internship and graduated in 1998. Julie is currently a member in good standing of the College of Dietitians of Ontario. With over 26 years of experience in oncology, she collaborates closely with a multidisciplinary team in the outpatient setting, providing guidance and support to patients across the cancer care continuum. Julie been instrumental in developing and enhancing the nutrition program using evidenced-based approaches and adhering to standards of practice. She has contributed to numerous initiatives at the Cancer Centre, including development of Enteral Nutrition Therapy Plans that were integrated in the EPIC electronic health record system, as well as the creation of educational videos aimed at helping patients manage common nutrition-related symptoms. Her most recent initiative involves working with colleagues to implement malnutrition screening into EPIC for patients with a head and neck, esophageal and lung cancer.

Original Source: "CNS 2025 Annual Conference" Saturday, May 10, 2025

The views expressed by speakers or other third parties in CNS webinars, events and/or conferences are those of the speaker or third-party and not necessarily of CNS.

CNS is committed to maintaining responsible and transparent processes with respect to support received from industry partners and sponsors for all CNS activities.  While input from industry partners and sponsors is valued by CNS, final control over session topics and content, speaker participation, award recipients, or other factors related to CNS activities is retained by the Society. All CNS conference program content, educational initiatives and award recipients are reviewed and approved by respective CNS committees.

Thanks to our sponsor, this recording is available at no cost.

Length: 1:03:46

Type: Video

Last Updated: June 24, 2025